MARSHALL WACE, LLP - LARIMAR THERAPEUTICS INC ownership

LARIMAR THERAPEUTICS INC's ticker is LRMR and the CUSIP is 517125100. A total of 49 filers reported holding LARIMAR THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of LARIMAR THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$266,854
+115.2%
58,908
+52.2%
0.00%
Q3 2022$124,0000.0%38,710
+239.8%
0.00%
Q4 2021$124,000
-59.5%
11,392
-57.2%
0.00%
-100.0%
Q3 2021$306,000
+27.5%
26,587
+8.5%
0.00%0.0%
Q2 2021$240,000
-69.6%
24,494
-54.7%
0.00%
-75.0%
Q1 2021$790,00054,1140.00%
Other shareholders
LARIMAR THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
CHI Advisors LLC 1,515,148$22,136,0004.43%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 5,144,539$75,162,0001.58%
SILVERARC CAPITAL MANAGEMENT, LLC 191,945$2,804,0001.53%
Atlas Venture Advisors, Inc. 292,184$4,269,0000.79%
Sio Capital Management, LLC 187,223$2,735,0000.56%
Vivo Capital, LLC 799,662$11,683,0000.41%
Altium Capital Management LP 93,261$1,363,0000.38%
RA Capital Management 1,515,151$22,136,0000.33%
Logos Global Management LP 230,000$3,360,0000.33%
DAFNA Capital Management LLC 81,432$1,190,0000.28%
View complete list of LARIMAR THERAPEUTICS INC shareholders